THYROID EYE DISEASE (TED)
Clinical trials for THYROID EYE DISEASE (TED) explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE (TED) trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE (TED), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection could reduce bulging eyes in thyroid disease
Disease control Not yet recruitingThis study tests a new medicine called KRIYA-586 (VV-14305) given as an injection around the eye. It is for people with moderate to severe thyroid eye disease, which can cause bulging eyes and discomfort. The study will check if the treatment is safe and if it helps reduce eye bu…
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 08:53 UTC
-
Could fewer infusions be enough for thyroid eye disease?
Disease control Not yet recruitingThis study compares a shortened 4-infusion course of the drug Teprotumumab (Tepezza) to the standard 8-infusion course in people with active thyroid eye disease. It aims to see if those who respond well early can safely stop treatment sooner. About 40 participants who show early …
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE4 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated May 17, 2026 08:50 UTC